Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹185 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹263 Cr
Mar2023₹224 Cr
Mar2022₹220 Cr
Mar2017₹185 Cr
Mar2016₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹263 Cr
17.45
Mar2023 ₹224 Cr
2.09
Mar2022 ₹220 Cr
18.85
Mar2017 ₹185 Cr
0.50
Mar2016 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,727.7 Cr -2.8% -4.1% 23.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr -2.1% 1.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -1.5% 1.5% 46.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 2.5% 11.2% 15.3% Stock Analytics
CIPLA ₹119,184.0 Cr -1% -1.7% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr -0.1% -5% -5.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.8%

-4.1%

23.3%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses